Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2023

SELL
$131.98 - $163.75 $8,446 - $10,480
-64 Closed
0 $0
Q3 2021

May 09, 2023

BUY
$106.4 - $120.78 $6,809 - $7,729
64 New
64 $6.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mc Carthy Grittinger Financial Group, LLC Portfolio

Follow Mc Carthy Grittinger Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Carthy Grittinger Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Carthy Grittinger Financial Group, LLC with notifications on news.